Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Other Non Operating Income (2017 - 2025)

Ironwood Pharmaceuticals' Other Non Operating Income history spans 5 years, with the latest figure at $77000.0 for Q4 2025.

  • For Q4 2025, Other Non Operating Income changed N/A year-over-year to $77000.0; the TTM value through Dec 2025 reached $193000.0, changed N/A, while the annual FY2025 figure was $193000.0, 69.84% down from the prior year.
  • Other Non Operating Income for Q4 2025 was $77000.0 at Ironwood Pharmaceuticals, up from $40000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $77000.0 in Q4 2025 and bottomed at $37000.0 in Q1 2025.